Annexon (ANNX) Cash from Financing Activities (2019 - 2026)

Annexon's (ANNX) quarterly Cash from Financing Activities came in at $32.9 million in Q1 2026, up 55655.93% year-on-year from N/an in Q1 2025, and down 65.4% quarter-over-quarter from $95.1 million in Q4 2025.

Annexon (ANNX) Cash from Financing Activities (2019 - 2026) Analysis & Trends

Annexon's Cash from Financing Activities history runs 8 years deep, the most recent figure standing at $32.9 million for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 55655.93% year-over-year to $32.9 million in Q1 2026; TTM through Mar 2026 was $141.7 million, a 9.96% increase from a year earlier, with the FY2025 full-year figure at $108.9 million, down 32.47% from the prior year.
  • Cash from Financing Activities slipped to $32.9 million in Q1 2026 per ANNX's latest filing, from $95.1 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $123.7 million in Q2 2024 and bottomed at $19000.0 in Q1 2022.
  • The 5-year median for Cash from Financing Activities is $9.3 million (2024), against an average of $35.1 million.
  • Across the five-year window, Cash from Financing Activities jumped 168138.36% in 2022 and slumped 99.88% in 2025, its largest moves.
  • Year by year, Cash from Financing Activities stood at $108000.0 in 2022, then surged by 108787.04% to $117.6 million in 2023, then tumbled by 95.78% to $5.0 million in 2024, then jumped by 1814.21% to $95.1 million in 2025, then tumbled by 65.4% to $32.9 million in 2026.
  • Per Business Quant, the three latest ANNX Cash from Financing Activities figures stand at $32.9 million (Q1 2026), $95.1 million (Q4 2025), and $13.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 30.14 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 53,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 68.63 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 238.74 Mn
10 Annexon 1.02 Bn 798.41 Mn - 32.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 32.90 Mn
Mar 31, 2026 32.90 Mn
Dec 31, 2025 95.08 Mn
Dec 31, 2025 95.08 Mn
Sep 30, 2025 13.56 Mn
Sep 30, 2025 13.56 Mn
Jun 30, 2025 153,000.00
Jun 30, 2025 153,000.00
Mar 31, 2025 59,000.00
Mar 31, 2025 59,000.00
Dec 31, 2024 4.97 Mn
Dec 31, 2024 4.97 Mn
Sep 30, 2024 175,000.00
Sep 30, 2024 175,000.00
Jun 30, 2024 123.65 Mn
Jun 30, 2024 123.65 Mn
Mar 31, 2024 32.41 Mn
Mar 31, 2024 32.41 Mn
Dec 31, 2023 117.60 Mn
Dec 31, 2023 117.60 Mn